The Bob Harrington Show

View all posts »

#44: Improving patient adherence to medication with Dr Eric Peterson

Jan 9, 2012 15:45 EST


Patient adherence to medication has long defied quantification, with many physicians assuming that the cost of medications is the primary factor explaining poor rates of compliance. The MI FREEE trial conducted by Dr Niteesh Choudry, and presented during AHA 2011 offers stunning proof that compliance is a more complicated issue than cost alone and raises numerous issues that our guest Dr Eric Peterson discusses. How do we explain abysmal rates of patient adherence to medication? Should the physician be held responsible for adherence?

See:

Cutting copays for post-MI drugs helps outcomes, with no added cost to insurers

Choudhry N, Avorn J, Glynn R, et al. The impact of full coverage for preventative medications after myocardial infarction on recurrent vascular events and health spending: The post-myocardial infarction free Rx event and economic evaluation (MI FREEE) trial. N Engl J Med 2011; DOI: 10.1056/NEJMsa110793. Available at: http://www.nejm.org

Aetna. Aetna launching value-based program that improves medication adherence, cost and outcomes for members who have suffered from heart attacks [press release]. November 14, 2011. Available here.

Goldman L and Epstein AM. Improving adherence—money isn't the only thing. N Engl J Med 2011; DOI:10.1056/nejme1111558. Available at: http://www.nejm.org.

Dr Peterson has received grants for clinical research from Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, and Sanofi-Aventis

For Dr Harrington's disclosures, click here.








Your comments
#44: Improving patient adherence to medication with Dr Eric Peterson
# 1 of 1
February 20, 2012 07:37 (EST)
Richard David Feinman
I don't know about being held responsible but it seems that it is part of the job to encourage compliance with medication. Isn't the objection to low carbohydrate diets that people won't stick with them (despite data in the literature that they have better adherence than other diets)? In lipid markers, metabolic syndrome and diabetes, diet can frequently give better results than drugs. Shouldn't physicians be trained in getting compliance.  Along which lines, isn't the continued use of intention-to-treat analysis inappropriate since efficacy and adherence may be under the conrol of different variables?

You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!